Evidence map›Paper›PMID 28075574›Full record

ArticleJournal of the American Chemical Society2017

Visualization of mycobacterial membrane dynamics in live cells.

Frances P Rodriguez-Rivera, Xiaoxue Zhou, Julie A Theriot, Carolyn R Bertozzi

Abstract read
In one paragraph

Article in Journal of the American Chemical Society, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 62 papers.

0numbers the graph read from it
0cells of the map it votes in
62citing papers in PubMed
8.1field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

62 citing papers in PubMed, 108 citations in OpenAlex.

  1. Review
  2. The mycomembrane proteins PorH and ProtX are inserted at polar growth zones and linked to the cell wall.Proceedings of the National Academy of Sciences of the United States of America · 2026
    Article
  3. Article
  4. Tre-DST: A Drug Susceptibility Test forACS infectious diseases · 2026
    Article
  5. Article
  6. Exploiting thioether reactivity to label mycobacterial glycans.Proceedings of the National Academy of Sciences of the United States of America · 2025
    Article
  7. Article
  8. Review
  9. Review
  10. Article
  11. Top five unanswered questions in bacterial cell wall research.Cell surface (Amsterdam, Netherlands) · 2024
    Review
  12. TargetingACS infectious diseases · 2024
    Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Molecular recognition of trehalose and trehalose analogues byProceedings of the National Academy of Sciences of the United States of America · 2023
    Article
  18. Article
  19. Exploring antibiotic resistance with chemical tools.Chemical communications (Cambridge, England) · 2023
    Review
  20. Review

2 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Frances P Rodriguez-RiveraDepartment of Chemistry, University of California , Berkeley, California 94720, United States.
Xiaoxue Zhou
Julie A TheriotHoward Hughes Medical Institute , Chevy Chase, Maryland 20815, United States.
Carolyn R BertozziDepartment of Chemistry, Stanford University , Stanford, California 94305, United States.ORCID 0000-0003-4482-2754
Howard Hughes Medical Institute · USUniversity of California, Berkeley · US

Funding

TRAINING & OUTREACH COREP50GM107615 · NIGMS · STANFORD UNIVERSITY · PI COVERT, MARKUS W · 2013 to 2017
$10.9M
Mycobacterial Sulfation PathwaysR01AI051622 · NIAID · UNIVERSITY OF CALIFORNIA BERKELEY · PI BERTOZZI, CAROLYN · 2002 to 2015
$6.0M
METABOLIC OLIGOSACCHARIDE ENGINEERINGR01GM058867 · NIGMS · UNIVERSITY OF CALIFORNIA BERKELEY · PI Carolyn Bertozzi · 1999 to 2026
$5.6M
Chemical MycobateriologyR37AI051622 · NIAID · STANFORD UNIVERSITY · PI BERTOZZI, CAROLYN · 2016 to 2025
$4.7M
Metabolic Engineering with Bioorthogonal Chemical ReportersR37GM058867 · NIGMS · UNIVERSITY OF CALIFORNIA BERKELEY · PI BERTOZZI, CAROLYN · 2009 to 2018
$4.7M
Actin-Based Motility of a Bacterial PathogenR37AI036929 · NIAID · UNIVERSITY OF WASHINGTON · PI THERIOT, JULIE A. · 2010 to 2019
$3.0M
ACTIN BASED MOTILITY OF A BACTERIAL PATHOGENR01AI036929 · NIAID · WHITEHEAD INSTITUTE FOR BIOMEDICAL RES · PI THERIOT, JULIE A. · 1995 to 2009
$2.2M
Howard Hughes Medical InstituteNIAID NIH HHS R01 AI036929NIAID NIH HHS R01 AI051622NIAID NIH HHS R37 AI036929NIAID NIH HHS R37 AI051622NIGMS NIH HHS P50 GM107615NIGMS NIH HHS R01 GM058867NIGMS NIH HHS R37 GM058867
6 · The paper itself

Abstract

Mycobacteria are endowed with a highly impermeable mycomembrane that confers intrinsic resistance to many antibiotics. Several unique mycomembrane glycolipids have been isolated and structurally characterized, but the underlying organization and dynamics of glycolipids within the cell envelope remain poorly understood. We report here a study of mycomembrane dynamics that was enabled by trehalose-fluorophore conjugates capable of labeling trehalose glycolipids in live actinomycetes. We identified fluorescein-trehalose analogues that are metabolically incorporated into the trehalose mycolates of representative Mycobacterium, Corynebacterium, Nocardia, and Rhodococcus species. Using these probes, we studied the mobilities of labeled glycolipids by time-lapse microscopy and fluorescence recovery after photobleaching experiments and found that mycomembrane fluidity varies widely across species and correlates with mycolic acid structure. Finally, we discovered that treatment of mycobacteria with ethambutol, a front-line tuberculosis (TB) drug, significantly increases mycomembrane fluidity. These findings enhance our understanding of mycobacterial cell envelope structure and dynamics and have implications for development of TB drug cocktails.

Indexed as

ThermodynamicsCell MembraneCell SurvivalEthambutolMembrane FluidityMycobacteriumEthambutol

Identifiers

PMID28075574
PMCPMC5345120
OpenAlexW2577815567

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.